Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
pivotal-trial
Press Release
Jun 1, 2022
Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design
Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction.
Read More
First
Prev
1
Next
Last